Citius Oncology, Inc. (CTOR) vs Inovio Pharmaceuticals, Inc. (INO)
A side-by-side comparison of Citius Oncology, Inc. and Inovio Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTOR
Citius Oncology, Inc.
$0.88HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
INO
Inovio Pharmaceuticals, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CTOR vs INO
growth of $100 · dividends reinvested · last 2yCTOR -92.4% (-72.4%/yr)INO -89.7% (-67.9%/yr)INO compounded faster over this window
CTOR INO
CTOR vs INO: by the numbers
- •CTOR is the larger company ($82M vs $80M market cap).
- •Both run net losses; CTOR's is the smaller (-648.32% vs -130000.00% net margin).
Metrics side by side
Valuation
| Metric | CTOR | INO |
|---|---|---|
| Forward P/E | 8.80 | N/A |
| P/S ratio | 11.52 | N/A |
| P/B ratio | 2.03 | 18.41 |
Profitability
| Metric | CTOR | INO |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -132871.32% |
| Net margin | -648.32% | -130000.00% |
| ROE | -114.06% | -1542.57% |
| ROIC | -88.72% | -836.58% |
Growth (annualized)
| Metric | CTOR | INO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -57.05% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.